Which Gene Plays a Role in Tumor Resistance?

April 26, 2018

Answer

The answer is Cp53.

Mutations of the p53 gene are associated with malignancies, and research suggests (https://www.ncbi.nlm.nih.gov/pubmed/25201193) that the mutation may increase the risk of chemotherapy resistance.  

A is not correct because NRAS mutations play a role in the development of a variety of cancers and most notably increase the risk of breast and ovarian cancer. However, the mutation has not shown to positively or negatively affect response (https://ghr.nlm.nih.gov/gene/NRAS) to chemotherapy.  

is not correct because APC gene mutations increase the likelihood of developing colorectal cancer but have not shown any effect (https://ghr.nlm.nih.gov/gene/APC) on chemotherapy response. 

D is not correct because the presence of a mutation to the VHL (Von-Hippel-Landau) gene will allow abnormal cell growth and division, leading to remarkably higher cancer rates, but has not demonstrated a significant impact (https://ghr.nlm.nih.gov/gene/VHL) on response to treatment. 


Copyright © 2018 by the Oncology Nursing Society. User has permission to print one copy for personal or unit-based educational use. Contact pubpermissions@ons.org for quantity reprints or permission to adapt, excerpt, post online, or reuse ONS Voice content for any other purpose.